H. V. Wyk

Clinical impact potential of Rejuveinix (RJX) for prevention of fatal acute respiratory distress syndrome (ARDS) and multi-organ failure in COVID-19 patients.

F. Uckun, K. Şahin, Natalie M. Pizzimenti, 2020 .